A phase II trial of circadian-timed paclitaxel and cisplatin therapy in metastatic breast cancer
Open Access
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (7) , 663-667
- https://doi.org/10.1023/a:1008228121390
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.Journal of Clinical Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Circadian cancer therapy.Journal of Clinical Oncology, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Circadian changes in estimated hepatic blood flow in healthy subjects.British Journal of Clinical Pharmacology, 1991
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- DNA synthesis in human bone marrow is circadian stage dependentBlood, 1991
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958